`
`
`
`
`
`
`
`
`Received 4th February, 1997.
`
`
`
`
`Accepted 26th July, 1997
`
`
`
`
`
`
`
`
`Indian J. Pharm. Scl., 1997, 59(5) pp. 232-235
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`In-Vitro studies on Buccal strips of Giibenciamide using Chitosan
`
`R. ILANGO‘, S. KAVlMANI, A. R. MULLAiCHARAM AND B. JAYAKAR.
`
`
`
`
`
`
`
`
`
`Dept. of Pharmaceutics. Periyar College of Pharmaceutical Sciences for Girls, Trichy, Tamil Nadu - 620 021.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`As giibenclamide is metabolised completely in the liver, the principal metabolite being only very weakly
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`active, buccai strip glibenclamlde may be very useful for the treatment of diabetes more efficiently. The
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`objective of this work Is to Investigate the possibility of obtaining a slow release, relatively constant
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`effective levels of glibenclamide from buccai strips using chitosan. Here attempts were made to develop
`
`
`
`
`
`
`
`
`
`
`
`
`suitable chitosan- based buccal strips and to characterise lt using different in vitro methods. Chitosan-
`
`
`
`
`
`
`
`
`
`
`
`
`
`based strlps of glibenclamlde showed suitability over Eudragit-based glibenclamlde buccai strips for
`controlled release behaviour.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`LIBENCLAMIDE is a Sulphonylurea group of
`G drug, used in the treatment of maturity onset
`
`
`
`
`
`
`
`
`
`
`
`
`
`diabetes as an oral hypoglycaemic1' 2, Giibenciam-
`
`
`
`
`
`ide, chemically is 1-(p-(2-(5-chloro-O-anisamido),
`
`
`
`
`
`ethyl), phenyi), sulfonyi)-3«cyciohexyl urea. The
`
`
`
`
`
`
`
`
`
`
`
`plasma half life is about 5-10 h. In the present work
`
`
`
`
`
`
`
`
`
`an attempt has been made to develop a buccai
`
`
`
`
`
`
`mucodhesive dosage form3‘7 of giibenclamide for
`
`
`
`
`
`
`
`improving and enhancing bioavailability. it may also
`
`
`
`
`
`
`
`
`
`be possible to bypass the hepatic first pass effect
`
`
`
`
`
`
`
`by administering it through the buccal mucosa, which
`
`
`
`
`
`
`
`
`
`is richly perfused with blood vessel and offers greater
`
`
`
`
`
`
`
`permeability than the skin4. The required therapeutic
`
`
`
`
`
`
`plasma concentration of glibenclamide can possibly
`
`
`
`
`
`
`
`
`be achieved more rapidly by using such buccai dos~
`
`
`
`
`age forms. Chitosan is (1-4)-2-amino-dexoy-fip~
`
`
`
`
`
`glucan.
`It has similar structural characteristics as
`
`
`
`
`
`
`that of giycosamino giycans. It is tough, biodegrad-
`
`
`
`
`able and non- toxic”.
`‘
`
`
`
`METHODS
`
`
`
`
`
`
`
`Giibenciamide (LP), chitosan, Eudragit L 100,
`
`
`
`
`
`EudragitS 100, Poiyvinyipyrroiidone (Koilidone), pro-
`
`
`
`
`
`
`
`pyleneglycol, acetic acid were the chemicals used.
`
`
`
`
`
`' *For correspondence
`
`
`
`
`
`
`
`Poiyvinyipyrroiidone was used as a mucoadhes-
`
`
`
`
`
`
`
`
`
`ive polymer. Propylene glycol (5% v/v) was used as
`
`
`
`
`
`
`
`a plasticizer and penetration enhancer. One percent
`
`
`
`
`
`
`
`
`
`
`w/v of chitosan was prepared in 5% v/v of acetic
`acid. Giibenciamide in concentration of 1% and 2%
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`were used. The chitosan buccai strips were prepared
`by casting technique“). Mixed quantity of chitosan
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`that was required to produce 1% w/v of its solution
`
`
`
`
`
`
`
`
`
`
`
`with 5% v/v of acetic acid. Allowed to stand for one
`
`
`
`
`
`
`
`
`
`and half weeks with moderate stirring for the first
`
`
`
`
`
`
`
`
`
`3-4 days. The solution was then filtered through a .
`
`
`
`
`
`
`
`muslin cloth to remove debris and suspended
`
`
`
`
`particles. Poiyvinyipyrroiidone was accurately
`
`
`
`
`
`
`weighed and dissolved in ethanol alongwith accu-
`
`
`
`
`
`
`
`rately weighed quantity of chitosan solution and pro—
`
`
`
`
`
`
`
`
`
`pylene glycol (5% v/v) were added to obtain aviscous
`
`
`
`
`
`
`
`sol’ution. The drug was then dispersed uniformly in
`
`
`
`
`
`
`
`the viscous solution with continous stirring. The re-
`
`
`
`
`
`
`
`sulting mass was then poured into glass moulds
`
`
`
`
`
`
`
`lined with Aluminiumfoil. The solventwas evaporated
`
`
`
`
`
`
`
`
`at room temperature for about 24 hours. The dried
`
`
`
`
`
`
`
`
`strip thus obtained was cut into required size con-
`
`
`
`
`
`
`
`
`sisting of required amount of the drug and stored
`
`
`
`
`
`
`
`
`in a dessicator. Strips having an oval form of 4 cm
`
`
`
`
`
`
`
`
`length and 3 cm width, 40 micron thickness and
`
`
`
`
`
`
`
`density 1.2031205 were used for the studies.
`
`
`
`
`
`
`
`
`
`
`
`
`232
` (cid:9)
`
`Indian Journal of Pharmaceutical Sciences
`
`
`
`
` (cid:9)
`
`September — October 1997
`
`
`
`
`
`
`Dr. Reddy’s - EXIOOS
`
`Page 1
`
`Dr. Reddy's - EX1005
`Page 1
`
`
`
`
`
`
`
`
`
`
`Table 1: Composition of glibenclamide buccal strips
`—______——________——————————_—
`
`lngredients
`
`
`
`
`
`
`Eudragit strip
`i Chltosan strip
`
` (cid:9)
`
`
`
`
`
`
`
`
`Control
`2% Drug
`1% Drug
`1% Drug
`2% Drug
`___________—____..____.._______——_—~——-——
`
`Glibenclamide
`
`
`
`Chitosan
`
`
`
`Eudragit
`Acetic Acid
`
`Ethanol
`
`
`
`
`
`'
`
`1%
`
`1%
`
`
`
`
`--
`
`‘
`
`5%
`
`
`
`--
`
`2%
`
`1%
`
`
`
`
`--
`
`5%
`
`
`
`--
`
`1%
`
`
`
`--
`
`1%
`
`
`
`--
`
`5%
`
`
`
`2%
`
`
`
`--
`
`1%
`
`
`
`--
`
`5%
`
`
`
`
`500 mg
`
`
`
`
`500 mg
`
`
`
`
`500 mg
`
`
`
`
`500 mg
`
`
`
`
`
`2%
`
`
`
`--
`
`--
`
`--
`
`5%
`
`
`
`
`500 mg
`
`
`
`
`
`Poly vinyl
`pyrrolidone
`
`
`
`
`
`
`
`
`_ 5%Propylene Glycol 5% 5% 5% 5%
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Table 2 : Swelling studies of buccal strips* (in CM)
`
`
`
`
`
`
`
`
`
`
`Eudragit buccal strip
`Chitosan buccal strip
`Time In
`
`
`
`
`
`
`
`
`
`1% Drug
`1% Drug
`2% Drug
`2% Drug
`minutes
`
`
`O
`
`5
`
`
`
`10
`
`30
`
`60
`
`
`
`
`
`3.0
`
`
`3.2 + 0.002
`
`
`3.8 + 0.05
`
`
`4.2 + 0.03
`
`
`4.3 + 0.2
`
`
`
`
`
`
`
`
`
`
`3.0
`
`
`3.3 + 0.002
`
`
`3.6 + 0.04
`
`
`4.0 + 0.1
`
`
`4.2 + 0.4
`
`
`
`
`
`
`
`
`
`3.0
`
`
`3.05 + 0.002
`
`
`3.09 + 0.006
`
`
`3.15 + 0.005
`
`
`3.2 + 0.001
`
`
`
`
`
`
`
`
`3.0
`
`
`3.04 + 0.002
`
`
`3.08 + 0.004
`
`
`3.15 + 0.07
`
`
`3.18 + 0.06
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`5, 10, 30 and 60 minutes intervals blotted with filter
`
`
`
`
`
`
`
`
`paper to remove the water present on their surface
`
`
`
`
`
`
`and weighed accurately. The percent swelling was
`
`
`
`
`
`calculated using the following formula“.
`
`
`
`
`
`
`
`
`Percentage Swelling = we‘ Wfigmvgghtve' ht X100
`
` (cid:9)
`
`
`
`
`I
`
`I
`
`'
`
`_
`
`'
`
`
`
`
`
`
`
`
`
`Density Determination of the strips was made
`
`
`
`
`
`
`
`
`employing the film thickness and by using the relation
`D=m/v
`
`
`
`
`
`
`
`
`
`
`
`
`Where D = Density of free strips
`
`
`
`
`
`
`
`M = Wt of strip samples in grams
`
`
`
`
`
`
`
`and V : Volume of strip sample (cm)3
`
`
`
`
`
`
`
`
`* Average of Three Trials with Standard deviation
`
`
`
`
`
`
`
`
`
`For Eudragit buccal strip preparation (1:1) ratio
`
`
`
`
`
`
`
`
`
`of Eudragit L 100 and Eudragit S 100 were used
`instead of chitosan solution. Ethanol was used as
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`solvent for Eudragit buccal strips. Drug free strips
`
`
`
`
`were prepared for comparison.
`
`
`
`
`
`
`
`
`
`Evaluation of Buccal strips
`
`
`
`
`
`
`
`
`
`
`
`
`Buccal strips of 4 cm length and 3 cm width
`
`
`
`
`
`
`
`were placed petridishes, 50 ml water was added
`
`
`
`
`
`
`
`
`
`and surface diameter was measured at 0, 5, 10, 30
`
`
`
`
`
`
`
`and 60 minutes intervales. Four replications of each
`
`
`
`
`
`
`
`
`test were carried out. Buccal strips of equal density
`
`
`
`
`
`
`(1.203) were weighed accurately and kept immersed
`
`
`
`
`
`
`
`
`
`
`in 50 ml of water. Strips were taken out carefully at
`
`
`
`
`
`
`
`
`
`September — October 1997
`
`
`
` (cid:9)
`
`Indian Journal of Pharmaceutical Sciences
`
`
`
`
`
` (cid:9)
`
`
`
`
`‘
`
`233
`
`
`
`Page 2
`
`Page 2
`
`
`
`
`
`
`
`
`Effect of concentration on drug release
`
`
`
`100
`
`
`
`1O
`
`V0
`
`
`
`80
`
`70
`60
`
`10
`
`40
`
`30
`
`20
`
`
`
`A
`
`D
`
`C
`
`D
`
`
`
`
`
`
`
`A — Chitosan Strip (1% Drug)
`
`
`
`
`
`
`B — Eudragit Strip (1% Drug)
`
`
`
`
`
`C — Chitosan Strip (2% Drug)
`
`
`
`
`
`
`D — Eudragit Strip (2% Drug)
`
`
`
`
`
`
`
`
`
`
`
`
`PERCENTAGECFDRUGRELEASE
`
`
`
`
`
`
`Table 3 : Percentage swelling of chitosan
`
`buccal* strips
`
`
` (cid:9)
`
`
`
`
`Chitosan strips
`Chitosan strips
`Time In
`
`
`
`
`
`
`2 % Drug
`Minutes
`1% Drug
`
`
`5
`
`
`10
`
`15
`
`30
`
`'60
`
`
`
`
`
`
`
`
`
`24 1 0.02
`
`
`27 1 0.05
`
`
`29 4.- 2.3
`
`
`31 :32
`
`
`
`32 t 2.21
`
`
`
`
`
`
`
`
`
`
`
`20 1 0.02
`
`
` (cid:9)
`26 1 0.02
`
`
` (cid:9)
`28.5 t 2.5
`
`
`3021.6
`
`
`
`31.5 t 0.06
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`* Values expressed as the mean of four readings with
`SD.
`
`
`
`
`The thickness of each film was measured in the
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`centre and around the periphery with a horizontal
`
`
`
`
`
`metroscope. All thickness and weight measurements
`were made after residual moisture has been removed
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`from the samples by storing in a dessicator for
`1 week.
`
`
`
`
`
`
`
`
`
`
`
`
`In Vitro release study
`
`
`
`
`
`
`
`
`
`
`The strip was carefully pressed on to a micro-
`
`
`
`
`
`
`
`
`
`
`
`scopic slide. The slide was placed at an angle of 45°
`
`
`
`
`
`
`
`
`
`
`
`in a250 ml beaker containing 200 ml of pH 7.4 buffer
`
`
`
`
`
`
`
`
`
`preheated to 37°. The beaker was kept
`in 37°
`
`
`
`
`
`
`
`
`waterbath. A non agitated system was selected to
`
`
`
`
`
`
`
`
`
`eliminate any effect of turbulence on the release rate
`
`
`
`
`
`
`
`
`
`
`as to assure that no disruption of the strip occured.
`
`
`
`
`
`
`
`Periodic assay samples were obtained by removing
`
`
`
`
`
`
`
`
`the slide, stirring the solution and pipetting a 5 ml
`
`
`
`
`
`
`
`
`sample with a graduated pipette. whose tip was
`
`
`
`
`
`
`
`
`
`covered with a piece of muslin cloth. The slide was
`
`
`
`
`
`
`
`quickly reinserted, making sure that the strip re-
`
`
`
`
`
`mained completely immersed throughout the release
`
`
`
`
`
`
`
`study. The beaker was kept covered through-out the
`
`
`
`
`
`
`
`run to prevent evaporation. All samples were an-
`
`
`
`
`
`
`
`
`alysed using an UV spectrophotometer at 226 nm.
`
`
`
`
`RESULTS AND DISCUSSION
`
`
`
`
`
`
`
`
`
`
`
`There is no interaction between chitosan and
`
`
`
`
`
`glibenclamide which was confirmed by Infrared
`
`
`
`
`
`
`
`
`
`
`spectrum of physical mixture of chitosan and
`
`glibenclamide.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Chitosan buccal strips with 1% and 2% drug and
`
`
`
`
`
`
`
`
`Eudragit buccal strips with 1% and 2% drug were
`
`
`
`
`
`
`prepared and evaluated. The content uniformity of
`
`
`
`
`
`
`
`glibenclamide in the prepared buccal film was found
`
`
`
`
`
`
`
`
`to be satisfactory and was within 5% variation. Poly-
`
`
`
`
`
`
`vinylpyrrolidone was used as the mucoadhesive
`
`
`
`
`
`
`
`
`polymer which have a molecular weight of 49,000.
`
`
`
`
`
`
`
`This is water soluble hydrocolloid, mucoadhesive by
`
`
`
`
`
`
`
`
`the dissolution kinetics of the polymeric carrier.VThus
`
`
`
`
`
`
`
`
`the polymer dissolution was the rate controlling step
`
`
`
`
`
`
`
`in drug release. When a swellable polymeric matrix
`
`
`
`
`
`
`
`
`was made by incorporating chitosan or Eudragit with
`
`
`
`
`
`
`
`
`the polymer solution, delay in the dissolution of poly-
`
`
`
`
`
`
`
`mer due to swelling of the incorporated substances
`
`
`
`
`
`
`
`
`occurs. This leads to controlled release of drug from
`
`
`mucodhesive strips.
`
`
`
`
`
`
`
`
`
`
`Chitosan swells more than Eudragit, which may
`
`
`
`
`
`
`
`
`
`lead to controlled release of drug in case of buccal
`
`
`
`
`
`
`strips prepared with chitosan. The Eudragit polymer
`
`
`
`
`
`
`
`solution consisting of equal proportion of (1:1) Eu-
`
`
`
`
`
`
`
`
`
`dragit S 100 and Eudragit L 100. Eudragit S 100
`
`
`
`
`
`
`
`has swelling property whereas Eudragit L 100 has
`
`
`
`no swelling property.
`
`
`
`
`
`
`
`
`234
`
` (cid:9)
`
`Indian Journal of Pharmaceutical Sciences
`
`
`
`
`
` (cid:9)
`
`September —- October 1997
`
`
`
`
`
`
`Page 3
`
`Page 3
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` (cid:9)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` (cid:9)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` (cid:9)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` (cid:9)
`
`
`
`
`
`
`
` (cid:9)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` (cid:9)
`
`
`
`
`
`
`
`
`
` (cid:9)
`
`
`
`
`
`
`
`
`
`Page 4
`
`